- Excellent financial health (Piotroski 7/9)
- Healthy interest coverage ratio of 22.7x
- Lower volatility than the market (beta 0.25)
Green day on Tuesday for Santen Pharmaceutical Co., Ltd. stock after gaining 1.19%
(Updated on Jun 23, 2026)
The Santen Pharmaceutical Co., Ltd. stock price gained 1.19% on the last trading day (Tuesday, 23rd Jun 2026), rising from $12.16 to $12.30. During the last trading day the stock fluctuated 3.66% from a day low at $12.00 to a day high of $12.44. The price has been going up and down for this period, and there has been a 1.23% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 thousand more shares were traded than the day before. In total, 2 thousand shares were bought and sold for approximately $23.89 thousand.
The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.76% during the next 3 months and, with a 90% probability hold a price between $11.57 and $14.67 at the end of this 3-month period.
SNPHY Signals & Forecast
The Santen Pharmaceutical Co., Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $12.02 and $11.64. A breakdown below any of these levels will issue sell signals. Santen Pharmaceutical Co., Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, May 26, 2026, and so far it has fallen -2.15%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Santen Pharmaceutical Co., Ltd. stock
Santen Pharmaceutical Co., Ltd. finds support from accumulated volume at $11.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.439 (3.66%) between high and low. For the last week, the stock has had daily average volatility of 2.82%.
Our recommended stop-loss: $11.85 (-3.66%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 19 days ago.)
Trading Expectations (SNPHY) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect Santen Pharmaceutical Co., Ltd. to open at $12.25, and during the day (based on 14 day Average True Range), to move between $12.10 and $12.50, which gives a possible trading interval of +/-$0.400 (+/-3.31%) up or down from last closing price. If Santen Pharmaceutical Co., Ltd. takes out the full calculated possible swing range there will be an estimated 3.31% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $12.57 (2.20%) than the support at $11.88 (3.46%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Santen Pharmaceutical Co., Ltd. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Santen Pharmaceutical Co., Ltd. stock to perform well in the short-term.
Current score:
3.507
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 24, 2026 - $12.25 ( 0.415%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
SNPHY Performance
Trading levels for SNPHY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 12.69 | 3.15% |
| R2 | 12.52 | 1.79% |
| R1 | 12.42 | 0.95% |
| Price | 12.30 | |
| S1 | 12.08 | -1.78% |
| S2 | 11.98 | -2.62% |
| S3 | 11.81 | -3.98% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 12.58 | 2.28% |
| R1 | 12.57 | 2.20% |
| Price | 12.30 | |
| S1 | 11.88 | -3.46% |
| S2 | 10.82 | -12.03% |
| S3 | 10.33 | -15.98% |
SNPHY Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Mar 31, 2026 | Mar 31, 2026 | Jun 24, 2026 | $0.0948 | 0.799% |
| 2 | Mar 30, 2026 | Mar 30, 2026 | Jun 25, 2026 | $0.119 | 1.05% |
| 3 | Sep 30, 2025 | Sep 30, 2025 | Sep 30, 2025 | $0.128 | 1.13% |
| 4 | Mar 31, 2025 | Mar 31, 2025 | Jul 10, 2025 | $0.0881 | 0.781% |
| 5 | Sep 30, 2024 | Sep 30, 2024 | Dec 16, 2024 | $0.0792 | 0.748% |
FAQ
Click here for our free guide on how to buy Santen Pharmaceutical Co., Ltd. Stock.
Buy SNPHY
A sell signal from a double top formation was found on Tuesday, May 26, 2026 and based on theory for this formation the price should fall by -37.85% to $7.64 within 33 trading days (Tuesday, July 14, 2026) since signal was issued.